Watchful waiting in prostate cancer: review and policy proposals
- 28 October 2003
- journal article
- review article
- Published by Wiley in BJU International
- Vol. 92 (8) , 851-859
- https://doi.org/10.1046/j.1464-410x.2003.04493.x
Abstract
No abstract availableKeywords
This publication has 53 references indexed in Scilit:
- Extended Prostate Needle Biopsy Improves Concordance Of Gleason Grading Between Prostate Needle Biopsy And Radical ProstatectomyJournal of Urology, 2003
- Using splines to detect changes in PSA doubling timesThe Prostate, 2002
- PREOPERATIVE SERUM PROSTATE SPECIFIC ANTIGEN LEVELS BETWEEN 2 AND 22 NG./ML. CORRELATE POORLY WITH POST-RADICAL PROSTATECTOMY CANCER MORPHOLOGY: PROSTATE SPECIFIC ANTIGEN CURE RATES APPEAR CONSTANT BETWEEN 2 AND 9 NG./ML.Journal of Urology, 2002
- DEDIFFERENTIATION OF PROSTATE CANCER GRADE WITH TIME IN MEN FOLLOWED EXPECTANTLY FOR STAGE T1C DISEASEJournal of Urology, 2001
- How accurately does prostate biopsy Gleason score predict pathologic findings and disease free survival?The Prostate, 2001
- Outcomes for men with clinically nonmetastatic prostate carcinoma managed with radical prostactectomy, external beam radiotherapy, or expectant managementCancer, 2001
- PATTERNS OF TREATMENT OF PATIENTS WITH PROSTATE CANCER INITIALLY MANAGED WITH SURVEILLANCE: RESULTS FROM THE CaPSURE DATABASEJournal of Urology, 2000
- Impalpable Invisible Stage T1c Prostate Cancer: Characteristics and Clinical Relevance in 100 Radical Prostatectomy Specimens-A Different ViewJournal of Urology, 1997
- Progression in Untreated Carcinoma of the Prostate Metastatic to Regional Lymph Nodes (Stage T0 to 4,N1 to 3,M0,D1)Journal of Urology, 1995
- Observations on the doubling time of prostate cancer.The use of serial prostate-specific antigen in patients with untreated disease as a measure of increasing cancer volumeCancer, 1993